MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells

被引:28
作者
Funamizu, Naotake [1 ]
Lacy, Curtis R. [2 ]
Kamada, Minori [3 ]
Yanaga, Katsuhiko [1 ]
Manome, Yoshinobu [3 ]
机构
[1] Jikei Univ, Sch Med, Dept Surg, Tokyo 1058461, Japan
[2] Howard Univ, Sch Med, Washington, DC 20059 USA
[3] Jikei Univ, Sch Med, Dept Mol Cell Biol, Tokyo 1058461, Japan
关键词
microRNA-203; Puma; gemcitabine sensitivity; PANCREATIC-CARCINOMA CELLS; REPRESSING DELTA-NP63; TUMOR-SUPPRESSOR; P53; PROLIFERATION; MIGRATION; MIR-203; STEMNESS; ADENOCARCINOMA; GEMCITABINE;
D O I
10.3892/ijo.2015.3178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study investigated the relationship between microRNA-203 (miR-203) and the p53 upregulated modulator of apoptosis (Puma) in colon (HCT116) and lung cancer (A549) cells. Colon and lung cancer cell lines were selected for this study since a relationship between p53/miR-203 and p53/Puma has been established in both cancers. In the present study, adriamycin and nutlin-3 were used to activate p53, which induced both miR-203 and Puma expression in HCT116 cells. In contrast, HCT 116 cells with downregulated p53 showed decreased miR-203 and Puma expression. Importantly, we found that overexpressed miR-203 in HCT116 cells resulted in significantly increased Puma expression (P<0.05). Based on these findings, we hypothesized that another limb of the p53/Puma axis depends on miR-203 expression. To further validate this relationship, we used lung cancer cells (A549) and found that activated p53 increased both miR-203 and Puma expression. In addition, we found that Puma expression remained elevated in cells with overexpressed miR-203 in the presence of p53 downregulation. Cumulatively, our data purport that p53 not only increased Puma expression directly, but that it may also do so through miR-203. Additionally, functional studies revealed that miR-203 overexpression induced apoptosis and inhibited cell invasiveness.
引用
收藏
页码:1981 / 1988
页数:8
相关论文
共 46 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   RETRACTED: MicroRNA-203 inhibits malignant melanoma cell migration by targeting versican (Retracted Article) [J].
Bu, Pingyuan ;
Yang, Ping .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (01) :309-315
[3]   MicroRNA expression profiles of esophageal cancer [J].
Feber, Andrew ;
Xi, Liqiang ;
Luketich, James D. ;
Pennathur, Arjun ;
Landreneau, Rodney J. ;
Wu, Maoxin ;
Swanson, Scott J. ;
Godfrey, Tony E. ;
Litle, Virginia R. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (02) :255-260
[4]   MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells [J].
Funamizu, Naotake ;
Lacy, Curtis Ray ;
Parpart, Sonya T. ;
Takai, Atsushi ;
Hiyoshi, Yukiharu ;
Yanaga, Katsuhiko .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) :725-734
[5]   Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma [J].
Funamizu, Naotake ;
Hu, Chaoxin ;
Lacy, Curtis ;
Schetter, Aaron ;
Zhang, Geng ;
He, Peijun ;
Gaedcke, Jochen ;
Ghadimi, Michael B. ;
Ried, Thomas ;
Yfantis, Harris G. ;
Lee, Dong H. ;
Subleski, Jeffrey ;
Chan, Tim ;
Weiss, Jonathan M. ;
Back, Timothy C. ;
Yanaga, Katsuhiko ;
Hanna, Nader ;
Alexander, H. Richard ;
Maitra, Anirban ;
Hussain, S. Perwez .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (04) :785-794
[6]   Tetrahydrouridine Inhibits Cell Proliferation through Cell Cycle Regulation Regardless of Cytidine Deaminase Expression Levels [J].
Funamizu, Naotake ;
Lacy, Curtis Ray ;
Fujita, Kaori ;
Furukawa, Kenei ;
Misawa, Takeyuki ;
Yanaga, Katsuhiko ;
Manome, Yoshinobu .
PLOS ONE, 2012, 7 (05)
[7]   Hydroxyurea Decreases Gemcitabine Resistance in Pancreatic Carcinoma Cells With Highly Expressed Ribonucleotide Reductase [J].
Funamizu, Naotake ;
Kamata, Yuko ;
Misawa, Takeyuki ;
Uwagawa, Tadashi ;
Lacy, Curtis Ray ;
Yanaga, Katsuhiko ;
Manome, Yoshinobu .
PANCREAS, 2012, 41 (01) :107-113
[8]   Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase? [J].
Funamizu, Naotake ;
Okamoto, Aikou ;
Kamata, Yuko ;
Misawa, Takeyuki ;
Uwagawa, Tadashi ;
Gocho, Takeshi ;
Yanaga, Katsuhiko ;
Manome, Yoshinobu .
ONCOLOGY REPORTS, 2010, 23 (02) :471-475
[9]   RETRACTED: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers (Retracted Article) [J].
Garofalo, Michela ;
Romano, Giulia ;
Di Leva, Gianpiero ;
Nuovo, Gerard ;
Jeon, Young-Jun ;
Ngankeu, Apollinaire ;
Sun, Jin ;
Lovat, Francesca ;
Alder, Hansjuerg ;
Condorelli, Gerolama ;
Engelman, Jeffrey A. ;
Ono, Mayumi ;
Rho, Jin Kyung ;
Cascione, Luciano ;
Volinia, Stefano ;
Nephew, Kenneth P. ;
Croce, Carlo M. .
NATURE MEDICINE, 2012, 18 (01) :74-82
[10]   Micro-RNA profiling in kidney and bladder cancers [J].
Gottardo, Fedra ;
Liu, Chang Gong ;
Ferracin, Manuela ;
Calin, George A. ;
Fassan, Mattect ;
Bassi, Pierfrancesco ;
Sevignani, Cinzia ;
Byrne, Dolores ;
Negrini, Massimo ;
Pagano, Francesco ;
Gomella, Leonard G. ;
Croce, Carlo M. ;
Baffa, Raffaele .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) :387-392